Frontiers in Oncology is delighted to present the Innovations in… series of article collections.
The oncology field has changed at a dramatic rate due to pioneering advances in technology. This could not have been achieved without a large amount of resources and breakthrough patents in the field.
Innovations in Cancer Genetics will publish high-quality studies on novel technologies and therapeutic advances in the field. It aims to highlight the impact of new breakthroughs in Cancer Genetics, whilst emphasizing important directions and new possibilities for future studies. We welcome Original Research, Review Articles or Opinion Articles on the novel technologies and therapeutics including the advantages and limitations of each.
To differentiate from our “Methods in…” series, this collection exclusively publishes new technologies and innovations based on recent approved patents or pending patents, more experimental research would be more suited to our Methods collection.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Frontiers in Oncology is delighted to present the Innovations in… series of article collections.
The oncology field has changed at a dramatic rate due to pioneering advances in technology. This could not have been achieved without a large amount of resources and breakthrough patents in the field.
Innovations in Cancer Genetics will publish high-quality studies on novel technologies and therapeutic advances in the field. It aims to highlight the impact of new breakthroughs in Cancer Genetics, whilst emphasizing important directions and new possibilities for future studies. We welcome Original Research, Review Articles or Opinion Articles on the novel technologies and therapeutics including the advantages and limitations of each.
To differentiate from our “Methods in…” series, this collection exclusively publishes new technologies and innovations based on recent approved patents or pending patents, more experimental research would be more suited to our Methods collection.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.